Bio-Cimetidine is applied in addressing several conditions characterized by periods of heightened symptoms, primarily those linked to conditions involving inflammatory or irritative processes, which may otherwise create noticeable physiological strain. The therapeutic domains for this medicine are considered relevant in conditions characterized by periods of heightened symptoms.

It is commonly used for the management of conditions presenting with systemic or localized discomfort, including active duodenal ulcer, active benign gastric ulcer, and symptoms related to gastroesophageal reflux disease (GERD). It may assist with supportive maintenance therapy for conditions where recurrence may be a concern, and is relevant for easing symptoms associated with pathological hypersecretory conditions, such as Zollinger-Ellison Syndrome.

The medicine contributes to easing the overall symptom load, particularly symptoms related to physical discomfort. In relevant clinical contexts, this type of therapy is applied in addressing acute or unstable symptom patterns. This provides supportive relief that helps improve day-to-day comfort during symptomatic periods and supports patients during episodes of heightened discomfort.

Quick Fact: Assists with Symptoms related to Physical Discomfort

Regulatory References

1. Label: CIMETIDINE tablet, film coated - DailyMed - NIH

Who can and cannot use Bio-Cimetidine?

The eligibility profile for Bio-Cimetidine (Cimetidine) is strictly defined by official regulatory labeling, outlining specific populations that must not use the medicine and others for whom use is restricted or conditional.

---

Absolute Non-Eligibility (Contraindications)

Bio-Cimetidine is contraindicated and must not be used by individuals with a known hypersensitivity or allergy to the active substance cimetidine or to any of the excipients in the formulation.

---

Populations Requiring Conditional Use

Use is primarily established for the adult population.

Eligibility Domain	Condition and Restriction
Age Restrictions	Pediatric use is restricted; use in children under 2 years old is not fully evaluated. For Over-The-Counter use, the medicine is generally for those 12 years and older. Use in older adults is permitted but requires caution due to the greater possibility of decreased renal function.
Organ Function	Dose modification is necessary for patients with impaired renal function due to the drug’s excretion route. Caution is also advised when treating patients with known hepatic impairment.
Physiological States	Use is restricted during pregnancy and lactation and should be avoided unless deemed essential by a physician.
Comorbidities	Caution is required for patients with conditions like porphyria or in the presence of a gastric ulcer until underlying malignancy has been officially ruled out.

Interactions with other medicines and products

The official interaction profile for Cimetidine (Bio-Cimetidine) is structured by its documented effects on drug metabolism and transport, primarily through the inhibition of multiple Cytochrome P450 (CYP) enzymes (including CYP1A2, CYP2C9, CYP2D6, and CYP3A4) and the organic cation transporter 2 (OCT2) in the kidney.

This mechanism results in elevated plasma concentrations of co-administered medicines, necessitating careful management or avoidance of certain combinations. Combinations that are Contraindicated due to the high risk of serious adverse effects include the antiarrhythmic Dofetilide and the antipsychotic Pimozide, where Cimetidine significantly increases their levels.

Interacting Product Category	Example Medicines/Agents	Practical Implication
Anticoagulants (Oral)	Warfarin	Increased anticoagulant effect; requires dose adjustment and close monitoring of coagulation status.
Narrow Therapeutic Index Drugs	Theophylline, Phenytoin	Increased levels; requires therapeutic drug monitoring and dose adjustments.
pH-Dependent Absorption Drugs	Ketoconazole, Itraconazole	Reduced absorption of the co-administered drug; necessitates administration at least 2 hours apart.

Co-administration with other medicines, such as certain beta-blockers, tricyclic antidepressants, and some calcium channel blockers, also requires caution and potential dose modification to maintain safe plasma levels.

Histamine mathbfH2 Receptor Antagonism and Signal Interruption

Cimetidine's primary action is defined by its role as a competitive antagonist at the Histamine mathbfH2 receptor, located on the basolateral membrane of the gastric parietal cell. The molecule reversibly occupies the receptor binding site, preventing the endogenous agonist, histamine, from activating the receptor and initiating the signal for acid secretion.

---

Blocking the Intracellular Acid Cascade

The inhibition of the mathrmH2 receptor prevents the activation of the associated Adenylyl Cyclase/cAMP cascade inside the cell. This molecular cascade blockade leads to a pronounced physiological reduction in the capacity of the stomach to secrete hydrochloric acid, especially for both basal and nocturnal output.

---

Non-Therapeutic Secondary Enzyme Interaction

Cimetidine exhibits a secondary, non-acid-related biological interaction through the reversible inhibition of specific Cytochrome P450 (CYP) isozymes in the liver. This non-therapeutic mechanism defines the molecule’s biological interaction profile concerning metabolic processes.

Bio-Cimetidine (Cimetidine) is officially administered via the oral route using tablets or a liquid solution, and through parenteral preparations for Intravenous (IV) or Intramuscular (IM) injection in clinical settings.

Standard adult regimens for acute therapy include three primary schedules: 800 mg taken as a single dose at bedtime, 400 mg twice daily, or 300 mg four times daily. Following ulcer healing, maintenance therapy typically utilizes a reduced dose of 400 mg taken once daily at bedtime. The overall total daily dose must not exceed 2.4 g.

The duration of use is defined by the official purpose. Short-term acute courses usually last between 4 to 8 weeks. For over-the-counter (OTC) use, the duration for self-treatment is officially limited to 14 consecutive days.

For oral administration, the tablets can be taken up to 30 minutes before a meal for prevention, or with water for relief. Concurrent, simultaneous use of oral cimetidine and antacids is not generally recommended. When preparing the parenteral form, the injectable solution requires dilution and must be injected slowly over a defined period (e.g., not less than five minutes).

The dose adjustments are specified for certain populations. In cases of severe renal impairment, the dosage must be reduced, commonly to 300 mg every 12 hours. Pediatric patients over one year old are administered a weight-based dose of 25 to 30 mg/kg of body weight per day in divided doses. If a dose is missed, the instruction is to skip the missed dose and continue with the regular schedule, without taking a double dose.

Summary of Key Research Findings

Research has primarily explored Bio-Cimetidine (Cimetidine) in its indicated use as a histamine H2-receptor antagonist for conditions such as duodenal and gastric ulcers, gastroesophageal reflux disease (GERD), and pathological hypersecretory conditions like Zollinger-Ellison Syndrome. Studies consistently report that the agent reduces gastric acid secretion, which supports its use in these conditions.

Detailed Study Descriptions

Efficacy Research

Clinical trials focusing on peptic ulcer disease have described healing rates consistently higher than placebo. For instance, controlled studies in patients with duodenal ulcers reported average healing rates exceeding 80% after six weeks of therapy with various dosage regimens. Maintenance therapy studies have reported lower recurrence rates (ranging from 10% to 45% after one year) compared to placebo in preventing ulcer relapse.

Investigational Use

Beyond its primary indications, research has explored the use of Cimetidine in other areas, often associated with its potential to modulate the immune system. A systematic review of randomized controlled trials investigated its use in patients undergoing curative resection for colorectal carcinoma (CRC). Some, but not all, of these trials reported an observed difference in survival benefit and immunomodulatory effects in peripheral blood and tumor-infiltrating lymphocytes compared to baseline.

Safety and Long-Term Data

Cimetidine is generally considered well-tolerated. Common adverse events observed in studies include headache, dizziness, and mild transient gastrointestinal disturbances. Uncommon events such as confusional states, depression, and reversible impotence or gynecomastia have been reported, primarily with high doses, in the elderly, or in patients with pre-existing kidney or liver impairment. Long-term follow-up studies extending up to six years in patients with peptic ulcer disease have provided reassurance that continued use did not reveal previously unknown long-term hazards. However, monitoring of kidney and liver function remains a relevant consideration when interpreting test results.

Common questions about Bio-Cimetidine (FAQ)

Q: Is Bio-Cimetidine the same as regular Cimetidine?

Bio-Cimetidine contains the active ingredient Cimetidine. This substance is classified as a Histamine H2 receptor antagonist, often referred to as an H2 blocker. The names essentially refer to the same medicine and active component.

Q: How quickly does Bio-Cimetidine start working for heartburn?

Official product information suggests that maximum acid suppression is generally reached within about 45 to 90 minutes after taking the oral tablet. Individual response times may vary.

Q: What are the most common side effects people report with Bio-Cimetidine?

Regulatory documents list common side effects that occur in more than 1 in 100 patients. These often include headache, diarrhea, dizziness, and drowsiness. These effects are typically reported as mild and often transient.

Q: Is Bio-Cimetidine available over the counter, or is it prescription only?

The medicine is available in both formats, depending on the strength. Lower strengths are available for self-treatment as an Over-The-Counter (OTC) medication to relieve and prevent heartburn. Higher strengths of Bio-Cimetidine require a prescription from a healthcare professional.

Q: What is the difference between Bio-Cimetidine and antacids?

Bio-Cimetidine (Cimetidine) is an H2 blocker that reduces the amount of acid the stomach produces. Antacids work by simply neutralizing acid that is already present. For this reason, official information generally recommends against taking both products at the same time.

Q: Do you have to take Bio-Cimetidine forever if you have GERD?

Studies and regulatory labeling indicate that the medicine is often used for short courses, such as up to 12 weeks for the healing of severe Gastroesophageal Reflux Disease (GERD). For other conditions, a reduced dose is sometimes indicated for long-term maintenance therapy to prevent ulcer recurrence.

Q: What happens if I forget to take my Bio-Cimetidine dose?

The official guidance for a missed dose is to skip the dose you forgot and continue with your regular schedule. Official guidance recommends against taking a double dose to compensate for the missed one.

Q: Does Bio-Cimetidine interact with blood pressure medication?

Caution is advised when Cimetidine is taken with certain blood pressure medications, including some beta-blockers and calcium channel blockers. Regulatory information suggests that these combinations may necessitate dose modification or closer clinical monitoring by a healthcare provider.

Q: Can Bio-Cimetidine affect liver function test results?

Official reports indicate that transient increases in liver enzymes (serum transaminases) have been observed, which may be detected during routine liver function tests. These effects are generally reported as reversible upon discontinuation of the medicine.

Q: What should I do if I experience a mild rash while taking Bio-Cimetidine?

Skin rashes are documented as a common adverse reaction. If you notice a rash, or if you develop any severe reactions like blistering or peeling skin, it is important to contact a healthcare provider for medical advice.

Q: Is it safe to stop taking Bio-Cimetidine suddenly?

Some clinical reviews suggest that stopping H2 receptor antagonists like Cimetidine abruptly may, in some individuals, lead to a temporary increase in acid production, sometimes referred to as rebound acid hypersecretion. Any decision to stop or change the use of the medicine should be discussed with a healthcare professional.

Q: Does taking Bio-Cimetidine change how other medicines are absorbed?

Yes, Cimetidine can reduce stomach acidity, which may affect the absorption of certain other medicines that require a more acidic environment to dissolve. This includes medicines like Ketoconazole, whose effectiveness may be reduced if absorption is altered.

Q: Why do doctors prescribe Bio-Cimetidine for things other than just ulcers?

Beyond treating ulcers, regulatory documents indicate that Bio-Cimetidine is also prescribed to treat conditions like Gastroesophageal Reflux Disease (GERD). It is also used for pathological conditions where the stomach produces excessive acid, such as Zollinger-Ellison Syndrome.

Q: Is Bio-Cimetidine known to cause drowsiness?

Yes, drowsiness (somnolence) is listed in official documents as one of the common side effects of Cimetidine.

Q: Is Bio-Cimetidine safe to take with vitamins or supplements?

Long-term use of this class of medicine, which reduces stomach acid, may potentially lead to decreased absorption of some nutrients, such as Vitamin B12, iron, and folic acid. It is recommended to discuss all vitamins and supplements with a healthcare professional.

Q: Does Bio-Cimetidine have an effect on kidney function?

Cimetidine is primarily removed from the body by the kidneys. It can artificially elevate blood levels of a substance called serum creatinine, which is sometimes used to measure kidney function, but this is usually not a true sign of reduced function. Dose adjustments are necessary for patients with pre-existing kidney impairment.

Q: Are there specific foods or drinks to avoid while on Bio-Cimetidine?

Official labeling does not list specific foods or drinks that must be avoided while using Cimetidine. However, due to its effect on liver metabolism, higher levels of caffeine in the blood have been reported after taking the medicine.

Q: Can young adults (under 18) take Bio-Cimetidine?

For Over-The-Counter (OTC) use, the product is generally indicated for individuals 12 years of age and older. For prescription use in children, weight-based doses have been used in a limited number of pediatric patients under the supervision of a doctor.

Q: Why is Bio-Cimetidine sometimes prescribed at bedtime?

Regulatory studies show that a single dose taken at bedtime is highly effective in reducing nocturnal gastric acid secretion. This is beneficial because acid production remains active throughout the night, often contributing to symptoms like nighttime acid reflux.

Q: Does Bio-Cimetidine cause problems with mental clarity or confusion?

Uncommon effects on the Central Nervous System (CNS) have been reported, including confusional states and disorientation. These effects are documented as occurring most often in the elderly or in severely ill patients with existing kidney or liver problems.

Q: Is it normal to feel a bit nauseous when first starting Bio-Cimetidine?

Yes, nausea and vomiting are listed in official adverse reaction documents as common side effects that may occur. These are usually mild and may subside as the body adjusts to the medicine.

Q: Is Bio-Cimetidine effective for nighttime acid reflux?

Yes, the medicine is officially indicated to help relieve and prevent symptoms of acid reflux. Its strong effect on nocturnal basal gastric acid secretion makes it a commonly used treatment to manage acid production during the night.

Q: How long does it take for Bio-Cimetidine to heal an ulcer?

Official data indicates that for active duodenal ulcers, most patients show healing within 4 weeks of therapy. While treatment may sometimes continue, it is rarely needed for longer than 6 to 8 weeks at the full treatment dose.

Q: What are the signs of a serious side effect from Bio-Cimetidine?

Serious side effects, though rare, are listed in official documents. Indications that require consultation with a healthcare professional include fever, dark urine, yellowing of the skin or eyes (jaundice), chest pain, or a severe generalized rash with blistering or peeling.

Q: How does Bio-Cimetidine help with Zollinger-Ellison syndrome?

Zollinger-Ellison Syndrome is a condition characterized by excessive acid production. Bio-Cimetidine helps by acting as a competitive antagonist at the Histamine H2 receptor, effectively reducing this excessive gastric acid secretion.

Q: Are there any known interactions between Bio-Cimetidine and common antibiotics?

Cimetidine can inhibit certain Cytochrome P450 (CYP) enzymes in the liver. Since some antibiotics are metabolized by the same enzymes, this may slow the breakdown of the antibiotic, potentially leading to higher levels in the bloodstream. It is important that a healthcare provider is aware of all current medications being taken.

Q: Can people with a history of heart issues safely use Bio-Cimetidine?

Uncommon or rare cardiovascular effects, such as a rapid heart rate (tachycardia) or changes in heart rhythm (heart block), have been documented. It is recommended to inform a healthcare provider of any history of heart issues or underlying heart disease before use.

Q: What symptoms indicate Bio-Cimetidine is working?

The medicine is officially indicated for the effective relief and prevention of symptoms like heartburn and acid indigestion. A reduction or cessation of these symptoms serves as the primary indicator that the medicine is working as intended.

Q: Is there a generic version of Bio-Cimetidine available?

Yes, the active ingredient, Cimetidine, is widely available as a generic product. Generic versions are available in both the over-the-counter and prescription strengths.

Bio-Cimetidine (Cimetidine) tablets must be stored at controlled room temperature, which ranges from 20 C to 25 C (68 F to 77 F). The regulatory labeling permits brief temperature excursions up to 30 C.

Environmental and Container Requirements

To preserve product integrity, the medicine must be protected from light and stored away from excess heat and moisture. It must be kept in the original, light-resistant container, and the container must be kept tightly closed. For safety, the product must be kept out of the reach of children.

Disposal

Official instructions require that unused or expired Bio-Cimetidine, including any unused portions of injection solutions, be disposed of in accordance with local, regional, and national regulations for pharmaceutical waste.